ricochet64 / Shutterstock.com
Recent patent decisions in the life sciences sector are leading biotechnology companies to seek protection for their innovations by using alternatives to patents, with trade secrets the most viable, the BIO International Convention has heard.
If you have already subscribed please login.
If you have any technical issues please email tech support.
BIO 2015, trade secrets, biotech, DuPont, Michael Clarke, 2015 BIO International Convention
